ResMed Inc (RMD)
243.63
+2.08
(+0.86%)
USD |
NYSE |
Nov 21, 16:00
244.95
+1.32
(+0.54%)
After-Hours: 20:00
ResMed Market Cap: 35.76B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 35.46B |
| November 19, 2024 | 34.95B |
| November 18, 2024 | 35.15B |
| November 15, 2024 | 34.46B |
| November 14, 2024 | 33.97B |
| November 13, 2024 | 34.56B |
| November 12, 2024 | 36.29B |
| November 11, 2024 | 36.51B |
| November 08, 2024 | 37.05B |
| November 07, 2024 | 36.48B |
| November 06, 2024 | 36.06B |
| November 05, 2024 | 36.07B |
| November 04, 2024 | 35.76B |
| November 01, 2024 | 35.86B |
| October 31, 2024 | 35.59B |
| October 30, 2024 | 35.67B |
| October 29, 2024 | 35.88B |
| October 28, 2024 | 36.23B |
| October 25, 2024 | 37.59B |
| October 24, 2024 | 35.09B |
| October 23, 2024 | 34.85B |
| October 22, 2024 | 35.23B |
| October 21, 2024 | 35.24B |
| October 18, 2024 | 35.23B |
| October 17, 2024 | 35.17B |
| Date | Value |
|---|---|
| October 16, 2024 | 34.98B |
| October 15, 2024 | 35.11B |
| October 14, 2024 | 35.33B |
| October 11, 2024 | 35.30B |
| October 10, 2024 | 34.92B |
| October 09, 2024 | 34.79B |
| October 08, 2024 | 34.65B |
| October 07, 2024 | 34.09B |
| October 04, 2024 | 34.34B |
| October 03, 2024 | 35.00B |
| October 02, 2024 | 35.06B |
| October 01, 2024 | 35.04B |
| September 30, 2024 | 35.83B |
| September 27, 2024 | 35.08B |
| September 26, 2024 | 35.60B |
| September 25, 2024 | 35.33B |
| September 24, 2024 | 36.27B |
| September 23, 2024 | 36.17B |
| September 20, 2024 | 35.99B |
| September 19, 2024 | 35.70B |
| September 18, 2024 | 34.97B |
| September 17, 2024 | 36.86B |
| September 16, 2024 | 36.99B |
| September 13, 2024 | 36.58B |
| September 12, 2024 | 36.84B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
16.54B
Minimum
Mar 20 2020
43.32B
Maximum
Sep 08 2021
30.27B
Average
30.82B
Median
Market Cap Benchmarks
| Boston Scientific Corp | 134.86B |
| Globus Medical Inc | 11.56B |
| Abbott Laboratories | 203.38B |
| Haemonetics Corp | 4.292B |
| Becton Dickinson & Co | 65.16B |
Market Cap Related Metrics
| PE Ratio | 32.27 |
| PS Ratio | 7.477 |
| PEG Ratio | 1.430 |
| Price to Book Value | 6.884 |
| Price to Free Cash Flow | 26.69 |
| Price | 243.63 |
| Earnings Yield | 3.10% |
| PEGY Ratio | 1.379 |
| Operating PE Ratio | 24.25 |
| Normalized PE Ratio | 30.74 |